InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Willard Stephen H. Officer active across 2 companies, notably NRX Pharmaceuticals, Inc.. Aggregated, 4 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €55k. History available since 16 December 2022. The latest transaction was disclosed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Willard Stephen H is a declarant linked to Longeveron Inc. and NRX Pharmaceuticals, Inc., where he is Chief Executive Officer. The 4 filings in the recent sample cover the period from 2022-12-19 to 2026-07-06, with EUR 54978 in buys and EUR 0 in sells; the listed transaction nature is Retenue fiscale.